Subsequently, we wanted to investigate whether the effects of GRP78 manipulation could ameliorate the metabolic comorbidities of obesity, such as hepatic steatosis and impaired glucose homeostasis. The gene discussed is HSPA5; the disease is obesity due to melanocortin 4 receptor deficiency.